BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2011
View Archived Issues
New phase IIa data presented on sifalimumab in systemic lupus erythematosus
Read More
Sunitinib has limited efficacy in advanced adrenocortical carcinoma in phase II trial
Read More
Scientists at Pfizer prepare novel phosphodiesterase 8B inhibitors
Read More
New tubulin inhibitors synthesized by R&D-Biopharmaceuticals
Read More
Plexxikon presents novel protein kinase inhibitors
Read More
Tekmira secures licenses to two validated oncology targets from Alnylam Pharmaceuticals
Read More
Incyte seeks FDA approval for ruxolitinib in myelofibrosis
Read More
First subject enrolled in phase II study of ALD-401 in ischemic stroke
Read More
Ipsen discontinues development of irosustat as monotherapy
Read More
GTx confirms phase III program design for ostarine in NSCLC
Read More
BAY-80-6946 is well tolerated in first-in-human trial in advanced solid tumors
Read More
VTX-2337 exhibits safety/tolerability in phase I trial in advanced solid tumors
Read More
Auspex Pharmaceuticals claims new antagonists of dopamine D2 and/or D3 receptor
Read More
Belgian scientists disclose new nicotinic acetylcholine receptor modulators
Read More
New PARP-1 inhibitor JI-1260 is a candidate for stroke therapy
Read More
Sound Pharmaceuticals begins trial of SPI-1005 for hearing loss induced by loud music
Read More
BioMarin begins phase III trial of amifampridine phosphate in LEMS
Read More
Oxygen Biotherapeutics gains approval to expand STOP-TBI to India
Read More
Nektar Therapeutics reports interim phase I data on NKTR-181
Read More
Biogen Idec receives European approval for Avonex Pen
Read More
BioMimetic Therapeutics completes enrollment in trial of Augment Rotator Cuff Graft
Read More
Johnson & Johnson begins phase II study of JNJ-40411813 in schizophrenia
Read More
Emergent BioSolutions acquires anticancer candidate zanolimumab from TenX BioPharma
Read More
Almirall launches Actikerall in U.K. for treatment of actinic keratosis
Read More
Bayer HealthCare submits MAA to EMA for VEGF Trap-Eye in wet AMD
Read More
